We’ve mentioned the court case involving the Myriad breast cancer gene patents several times here at Cancer and Your Genes. Recently, we’ve discussed the rather surprising summary judgment decision invalidating some of Myriad Genetics’ patents on the BRCA1 and BRCA2 genes. This is just the opening salvo in a fight that may make it all the way to the Supreme Court.
If you have a compelling family history of breast and ovarian cancer that is not explained by a mutation in the BRCA1 or BRCA2 gene, it is possible that the RAD51C gene could be the explanation. An international research team demonstrated that mutations in RAD51C can lead to hereditary breast and ovarian cancer risk in a paper published online in Nature Genetics yesterday.
According to the show’s website, Christina Applegate will be appearing on Oprah today
The Wall Street Journal Health Blog has an interesting story on a brewing turf war between breast surgeons and plastic surgeons over breast reconstruction procedures.
A research group led by Dr. Stephen Taplin of the National Cancer Institute has published a paper in the June 18th issue of the Journal of the National Cancer Institute that assesses whether certain factors differing between mammography facilities are associated with better interpretive accuracy on screening mammograms.